RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. A19/231a
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 123
2024
-
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2
Journal of Medicinal Chemistry, year: 2024, volume: 67, edition: 15, DOI
-
Ligand bias underlies differential signaling of multiple FGFs via FGFR1
elife, year: 2024, volume: 12, edition: April 2024, DOI
-
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands
CYTOKINE & GROWTH FACTOR REVIEWS, year: 2024, volume: 78, edition: August 2024, DOI
2023
-
Lékařská biologie II. Genetika a molekulární medicína
Year: 2023, edition: Vyd. 1., number of pages: 227 s.
-
Nanodiamonds as artificial proteins for regulation of a cell signalling system
Publisher: European Patent Office, state: Germany, patent's number: EP3645018B1, year: 2023
-
Nanodiamonds as artificial proteins for regulation of a cell signalling system
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11744855B2, year: 2023
-
Skeletal diseases caused by mutations in PTH1R show aberrant differentiation of skeletal progenitors due to dysregulation of DEPTOR
Frontiers in Cell and Developmental Biology, year: 2023, volume: 10, edition: January 2023, DOI
-
Thermostable FGF2 polypeptide, use thereof
Publisher: Canadian Intellectual Property Office, state: Canada, patent's number: CA3006388, year: 2023
-
Thermostable FGF2 polypeptide, use thereof
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11746135B2, year: 2023
-
Thermostable FGF2 Polypeptide, Use Thereof
Publisher: Intellectual Property India, state: India, patent's number: IN485239, year: 2023